A Chicago-based private equity firm, Linden Capital Partners, has bought a majority stake in RQM+, a PA-based firm specializing in compliance, compliance quality, and regulatory consulting for medical device and in-vitro diagnostics producers.
According to a release from the firm, the deal will witness Chartwell Investments Entrepreneur & Founder Capital and DFW Capital Partners make an exit from the company. A couple of PE companies made an investment in October 2019 in predecessor consulting firm R&Q and then collaborated with merged it with UK-based Maetrics in September 2020 in order to make the biggest medical device-focused worldwide quality and regulatory consultancy.
Incoming board member of RQM+ & partner at Linden, Michael Farah, said that the company’s environment is a straight result of the company’s longstanding and dedicated outsourced medical device services segment attempt and they are happy to collaborate with a firm that has such a strong position in the market at present. He also added that they are eagerly looking forward to supporting the complete RQM+ team as they look up to grow both through acquisitions and organically as well.